Prostate-MRI

Lead Investigator: Wei, John — University of Michigan Recruiting

Coordinating Investigator: Feng, Ziding — Fred Hutchinson Cancer Research Center

Involved Investigator Sites:

• Olumi, Aria — Beth Israel Deaconess Medical Center
• Kibel, Adam — Brigham and Womens Hospital
• Chesnut, Gregory — Center for Prostate Disease Research Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center
• McClure, Tim — Cornell University
• Filson, Christopher — Emory University School of Medicine
• Feng, Ziding — Fred Hutchinson Cancer Research Center
• Pow-Sang, Julio — H. Lee Moffitt Cancer Center and Research Institute, inc.
• Chan, Daniel — Johns Hopkins Medical Institutions
• Watts, Kara — Montefiore Medical Center
• Crichton, Dan — NASA Jet Propulsion Laboratory
• Srivastava, Sudhir — National Cancer Institute
• Neidinger, Erik — Frederick National Laboratory for Cancer Research
• Sonn, Geoffrey — Stanford University Medical Center
• Rais-Bahrami, Soroush — University of Alabama at Birmingham
• Punnen, Sanoj — University of Miami
• Gaston, Sandra M. — University of Miami Miller School of Medicine
• Wei, John — University of Michigan Pathology
• Wei, John — University of Michigan Recruiting
• Lotan, Yair — UT Southwestern Medical Center at Dallas
• Barocas, Dan — Vanderbilt University
• Liss, Michael — The University of Texas Heath Science Center, San Antonio

Biomarker Name: PSA, PCA3, TMPRSS2:ERG, radiomics MRI imaging

Design: No design specified.

Field(s) of Research: Other, Specify

Collaborative Group: Prostate and Urologic Cancers Research Group

Phased Status: 2

Aims: TBD

Analytic Method: TBD

Comments:

Biomarkers:

There are currently no biomarkers annotated for this protocol.

Datasets:

• Prostate MRI